| Course Unit Code | Course Unit Title | Type of Course Unit | Year of Study | Semester | Number of ECTS Credits | | BD409.1 | Nutrient Drug Interaction | Elective | 4 | 7 | 3 |
|
| Level of Course Unit |
| First Cycle |
| Objectives of the Course |
| To explain the improving knowledge of interactions between some drugs and chemicals in the nutrients, applying these knowledge on nutritional program of people under drug treatment are aimed. |
| Name of Lecturer(s) |
| Dr. Öğretim Üyesi Fatma CEBECİ |
| Learning Outcomes |
| 1 | Students will learn the basic topics covering drug interactions with nutrients and non-nutrients. | | 2 | Students will learn how the absorption of medications or nutrients can be affected during treatment, particularly how oral medications can be affected by the presence of nutrients. | | 3 | Students will understand excretion-level interactions | | 4 | Students will learn the interactions between drugs and herbal/other products, and the underlying mechanisms. |
|
| Mode of Delivery |
| Second Education |
| Prerequisites and co-requisities |
| None |
| Recommended Optional Programme Components |
| None |
| Course Contents |
| Interactions between dietary factors (nutrients and nutrients) and drug or drug groups and other chemicals, which impact bioavailability, requirement and function of nutrients in animals and humans are topics which will be covered in module. |
| Weekly Detailed Course Contents |
|
| 1 | Introduction, basic terminology, pharmacovigilance | | | | 2 | Terms and definitions related with drug interactions | | | | 3 | An overview of pharmaceutical, pharmacodynamic, pharmacokinetic drug interactions | | | | 4 | Fundamentals of pharmacokinetics | | | | 5 | Pharmacokinetic drug interactions (absorption) | | | | 6 | Pharmacokinetic drug interactions (distribution) | | | | 7 | Pharmacokinetic drug interactions I (basics of biotransformation) | | | | 8 | MIDTERM EXAM | | | | 9 | Pharmacokinetic drug interactions (examples of interactions related with biotransformation) | | | | 10 | Pharmacokinetic drug interactions (elimination) | | | | 11 | Complementary and alternative med. and drug interactions | | | | 12 | Samples and case studies -1 | | | | 13 | Samples and case studies -2 | | | | 14 | Samples and case studies -3 | | | | 15 | General Discussion | | |
|
| Recommended or Required Reading |
| 1-Choe, JY (2011) Drug Actions and Interactions. McGraw Hill Medical.
2-Dasgupta, A, and Hammett-Stabler, CA (2011) Herbal Supplements: Efficacy, Toxicity, Interactions with Western Drugs, and Effects on Clinical Laboratory Tests. Wiley.
3-Demirezer LÖ (Ed.) (2011) FFD Monografları “Tedavide Kullanılan Bitkiler” Nobel Tıp Kitabevleri, Ankara
4-Kayaalp, S.O. (Ed.) (2012) Akılcıl Tedavi Yönünden Tıbbi Farmakoloji, Pelikan Yayıncılık, Ankara.
5-Lexicomp (2013) Drug Information Handbook: A Comprehensive Resource for all Clinicians and Healthcare Professionals. Wolter Kluwer Health.
6-Rodrigues, AD (2008) Drug-Drug Interactions. Informa Healthcare.
7-Vural, N (2005) Toksikoloji. Ankara Üniversitesi Eczacılık Fakültesi Yayınları |
| Planned Learning Activities and Teaching Methods |
|
| Assessment Methods and Criteria | |
| Midterm Examination | 1 | 100 | | SUM | 100 | |
| Final Examination | 1 | 100 | | SUM | 100 | | Term (or Year) Learning Activities | 40 | | End Of Term (or Year) Learning Activities | 60 | | SUM | 100 |
| | Language of Instruction | | Turkish | | Work Placement(s) | | None |
|
| Workload Calculation |
|
| Midterm Examination | 1 | 1 | 1 |
| Final Examination | 1 | 2 | 2 |
| Attending Lectures | 14 | 2 | 28 |
| Question-Answer | 14 | 2 | 28 |
| Self Study | 14 | 1 | 14 |
| Individual Study for Mid term Examination | 1 | 6 | 6 |
| Individual Study for Final Examination | 1 | 12 | 12 |
|
| Contribution of Learning Outcomes to Programme Outcomes |
| LO1 | 4 | 1 | 1 | 4 | 4 | 4 | 1 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | | LO2 | 4 | 1 | 1 | 4 | 4 | 4 | 1 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | | LO3 | 4 | 1 | 1 | 4 | 4 | 4 | 1 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | | LO4 | 4 | 1 | 1 | 4 | 4 | 4 | 1 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 |
|
| * Contribution Level : 1 Very low 2 Low 3 Medium 4 High 5 Very High |
 |
| |